Term
Is the following statement True or False?
Tetracyclines and sulfonamides are older bacteriostatic medications that are rarely used for systemic infections.
|
|
Definition
True.
Tetracyclines and sulfonamides are older, broad-spectrum, bacteriostatic medications that are rarely used for systemic infections because of microbial resistance and the development of more effective or less toxic drugs.
|
|
|
Term
Tetracyclines and Sulfonamides |
|
Definition
•Older, broad-spectrum bacteriostats
•Rarely used for systemic infections
–Due to microbial resistance
–Development of more effective/less toxic medications
•Urinary antiseptics
–Used only in UTIs
|
|
|
Term
|
Definition
•Effective against wide range of gram(+) and gram(-) microbes
•Not usually drug of choice
•Widely distributed into most body tissues and fluids
•Older medications are excreted mainly in urine
–Doxycycline eliminated in urine and feces
–Minocycline eliminated mainly by liver
|
|
|
Term
|
Definition
- Well absorbed:
- Highly lipid soluble reaches therapuetic levels in CSF the eye and prostate gland
- smaller dosage than tetracycline eliminated in urine and feces
|
|
|
Term
|
Definition
po/IV 100-200mg
older adults po |
|
|
Term
|
Definition
- well absorbed after oral
- like doxycline, readily penetrates the CSF
- metabolized more than other tetracyclines, and smaller
- eliminted by the liver
|
|
|
Term
|
Definition
po, 200mg initially then 100mg q12h
older 8y: po, 4 mg/kg initially, then 2 mg/kg q12 |
|
|
Term
|
Definition
richettsiae
chlamydia
protoza
spirochetes
Brucella
vibrio cholerae |
|
|
Term
|
Definition
Bacillus anthracis (anthrax)
Chlamydia trachomatis
Respiratory tract infection due to mycoplasma pneumiae |
|
|
Term
Tetracycline (achromycin) |
|
Definition
- UTI
- Prototype drug
- Marketed under generic and numerous
|
|
|
Term
Tetracycline (achromycine) treat by |
|
Definition
po 250-500 mg q6h
older than 8 years po 25-50 mg/kg/d in 4 divide doses |
|
|
Term
•Demeclocycline (Declomycin)
|
|
Definition
- tetraycline most likely to cause photosensitivity
- primarily used to treat inappropriate secretion of antidiuretic horome
- no longer recommend for treatment of gonorrhea
|
|
|
Term
Demeclocycline (Declomycin) |
|
Definition
po 150 mg q6h or 300 mg q12h
older than 8years po 8-12 mg/kg/d in 2-4 divided doses |
|
|
Term
Demeclocycline (Declomycin) |
|
Definition
may be used to inhibit antidiuretic horomone in the treatment of chronic inappropriate antidiuretic hormone secrection |
|
|
Term
|
Definition
•Bacteriostatic against wide range of gram(+) and gram(-) microbes
•Increasing resistance, decreasing efficacy
•Susceptibility should be documented by culture and sensitivity testing
•Some can be used in treatment of systemic infections
–Others exert only local effects
|
|
|
Term
|
Definition
- A short-acting rapidly absorbed & excreted agent for systemic infections
- The addition of folinic acid may be recommended
|
|
|
Term
Sulfadiazine clinical Indications |
|
Definition
Nocardiosis
Toxoplasmosis |
|
|
Term
Sulfadiazine routes and Dosage Range |
|
Definition
adults toxoplasmosis po 2-6 daily
in dived doses q 6h in conjunction w/ pyrimethamine
Nocardiosis 4-8 b/ day for minimum of 6 weeks |
|
|
Term
Sulfadiazine routes and Dosage Range |
|
Definition
childern toxoplasmosis older than 2 mo po75mg/kg initially, then 150 mg/kg/d in conjunction with pyri methamine in 4-6 divide doses maximal daily dose, 6g |
|
|
Term
Sulfasalazine (Azulfidine) |
|
Definition
- porly absobed
- dose not alter normal bacterial in the intestine
- effectiveness in ulcerative colitis may be due to antibacterial
|
|
|
Term
Sulfasalazine (Azulfidine) Clinical Indications |
|
Definition
Ulcerative colitis/ Crohn's disease
Rheumatoid arthritis |
|
|
Term
Sulfasalazine (Azulfidine) Routes and Dosage Ranges |
|
Definition
Adults Ulcerative colitis po 3-4g daily in 4 divided doses intially 2g daily in divided doses for maintenance maximal daily dose 4 g
Rheumatoid arthritis maintenance po 2g daily in divided doses q12h |
|
|
Term
Sulfasalazine (Azulfidine) Routes and Dosage Ranges |
|
Definition
Childern po 30-60mg/kg/d in 2-6 divided doses intially followed by 30mg/kg/d in 4 divided doses maximum daily dose 2g |
|
|
Term
|
Definition
- Rapidly absorbed rapidly excreted
- Highly soluble and less likely to cause crystalluria than most other sulfonamides
|
|
|
Term
Sulfisoxazole Clinical indications |
|
Definition
|
|
Term
Sulfisoxazole Routes and Dosage ranges |
|
Definition
Adult po 2-4g initially then 4-8g daily in 4-6 divided doses |
|
|
Term
Sulfisoxazole Routes and Dosage ranges |
|
Definition
Childern older than 2 mounths po 75mg/kg of body weight initially then 120-150mg/kg/d in 4-6 divided doses; maximal daily dose 6g |
|
|
Term
Trimethoprim sulfamethoxazole (Bactrim) |
|
Definition
May exhibit synergistic effectiveness against many organisms (verifysusceptibility first)
including streptococci (S. viridans) staphylococci (S. epidermidis, S aureus) Escherichia coli, Salmonella, Shigella, Serrtia Klebsiella, Nocardia, and others |
|
|
Term
Trimethoprim sulfamethoxazole (Bactrim) Clinical Indications |
|
Definition
- Acute and chronic UTI
- Acute exacerbations of chronic bronchitis
- Acute otitis media caused by susceptible strains of hemophilus influenzae and Streptococcus pneumoniae
- Shigellosis
- Infection by pneumocystis jiroveci (prevention and treatment)
|
|
|
Term
Trimethoprim sulfamethoxazole (Bactrim) Routes and Dosage Ranges |
|
Definition
- UTI trimethoprim 160mg and sulfamethoxazole 800 mg po q12h for 10-14 days
- Shigellosis same doses as above for 5 d
- Sever UTI , IV, 8-10 mg (trimethoprin component) kg/d in 2-4 divided doses, up to 14 d
|
|
|
Term
Trimethoprim sulfamethoxazole (Bactrim) Routes and Dosage Ranges |
|
Definition
Childern UTI and otitis media, po 8 mg/kg trimethoprim and 40 mg/ kg sulfamethoxazole in 2 divided doses q12h for 10d
Shigellosis same dose as above for 5 d
Sever Uti IV8-10mg (trimethoprim component )/kg in 2-4 divided doses, q 6-8hor q12, up to 14d |
|
|
Term
|
Definition
- Effective against most gram - negative and gram-negative and gram-positive organisms especially Pseudomonas aeruginosa
- Application cause pain and burning
- Mafenide is absorbed systemically and may produce metabolic acidosis
|
|
|
Term
Mafenide (Sulfamylon) Clinical Indications |
|
Definition
Prevention Of bacterial colonization and infection of severe burns |
|
|
Term
Mafenide (Sulfamylon) Routes and Dosage Ranges |
|
Definition
Topical application to burn area,onece or twice daily in a thin layer
In childern is the same as in adults |
|
|
Term
•Silver sulfadiazine (Silvadene)
|
|
Definition
Effective against most pseudomonas species the most common pathogen in severe burn sepsis E coli Klebsiella proteus Staphylococci and streptococci |
|
|
Term
•Silver sulfadiazine (Silvadene) Clinical Indications
|
|
Definition
SAme as mafenide usually the preferred drug |
|
|
Term
Silver sulfadiazine (Silvadene) Routres and Dosage Ranges |
|
Definition
Adults 1-2 times daily cover burned area w/ cream In childern is the same as in adults |
|
|
Term
|
Definition
•May be bactericidal because of local effects produced by high concentration levels in renal tubules and urine
•Not used for systemic infections
–Do not attain therapeutic plasma levels
|
|
|
Term
|
Definition
•Tetracyclines
–Penetrate microbial cells, inhibiting protein synthesis
•Sulfonamides
–Halt multiplication of new bacteria
–Do not kill mature, fully formed bacteria
|
|
|
Term
Is the following statement True or False?
Phenazopyridine is an antimicrobial used in the treatment of UTIs.
|
|
Definition
False.
Phenazopyridine is not an antimicrobial medication; it is administered to relieve pain associated with UTIs.
|
|
|
Term
Tetracycline Indications for Use |
|
Definition
•Drug of choice in specific infections
–Cholera, Rocky Mountain spotted fever, syphilis, typhus, H. pylori, etc
•Useful in animal bites, lyme disease
•Chlamydia infections; adjunct in STD treatment; prophylaxis/treatment of anthrax
•Long-term acne treatment; substitute for PCN in hypersensitivity
|
|
|
Term
Sulfonamide Indications for Use |
|
Definition
•UTI caused by E. coli, Proteus, Klebsiella organisms
•In combination to treat chronic bronchitis
•Ulcerative colitis, other uncommon infections
•Topically
–Prevention of burn wound infections
–Ocular and other soft tissue infections
|
|
|
Term
Urinary Antiseptic Indications for Use |
|
Definition
•Urinary antiseptics are used only for UTIs
|
|
|
Term
|
Definition
•Fosfomycin (Monurol)
•Methenamine mandelate (Mandelamine)
•Methenamine hippurate (Hiprex)
•Nalidixic acid (NegGram)
•Nitrofurantoin (Furadantin, Macrodantin)
•Phenazopyridine (Pyridium)
|
|
|
Term
Nitrofurantoin (Furadantin, Macrodantin) |
|
Definition
- Antibacterial activity against Ecoil and most other organisms that cause UTI
- Used for short-term treatment of UTI or long-term suppression of bacteria in chronic, recurrent UTI
- Bacterial resistance develops slowly and to a limited degree
- Contraindicated in severe renal disease
|
|
|
Term
Nitrofurantoin (Furadantin, Macrodantin) Routes and Dosage |
|
Definition
Macrodantin: PO 50-100 mg 4 times daily; Macrobid 100
mg q12h for 7 d
Prophylaxis of recurrent UTI in women Macrodantin PO 50-100mg at bedtime |
|
|
Term
Nitrofurantoin (Furadantin, Macrodantin) Routes and Dosage |
|
Definition
In childern: older than 12 years Dual-release capsules 100mg q12h for 7 days
Childern: i mounths and older PO macrocrystal capsules 5-7mg/kg/d in 4 divided dose for 7 days |
|
|
Term
Phenazopyridine (Pyridium) |
|
Definition
- An azo dye that acts as a urinary tract analgesic and relives sysmptoms of dysuria, burning, and frequency and urgency of urination, which occur with UTI
- It has no anti-infective action
- It turns urine orange- red which may be mistaken as blood
- It is contraindicated in renal insufficiency and sever hepatitis
|
|
|
Term
Phenazopyridine (Pyridium) Routes and Dosage Ranges |
|
Definition
Adults PO 100-200mg 3 times Daily after meals
Childern: 6-12 years 12mg/kg/day in 3 divided doses after meals |
|
|
Term
Contraindications for Use
•Tetracyclines and sulfonamides
|
|
Definition
–Clients with renal failure
•Tetracyclines
–Pregnant women
–Children aged <8 years
•Can discolor tooth enamel and depress bone growth
•
|
|
|
Term
Principles of Therapy
Tetracyclines
|
|
Definition
–Culture and susceptibility studies needed before therapy begun
•Due to drug resistance
–Oral route is effective and preferred
–Decompose with age, light exposure, extreme heat and humidity
•Medications must be stored correctly
|
|
|
Term
Principles of Therapy
•Sulfonamides and urinary antiseptics
|
|
Definition
–Culture and susceptibility studies needed before therapy begun
•Loading dose produces therapeutic blood levels more quickly
•Loading dose = twice maintenance dose
–Urine pH important in pharmacotherapy
|
|
|
Term
Is the following statement True or False?
Tetracyclines can be prescribed for the treatment of specific STDs.
|
|
Definition
True.
Tetracyclines can be prescribed for the treatment of certain chlamydial infections, pelvic inflammatory disease, and sexually transmitted diseases.
|
|
|
Term
|
Definition
•Children
•Older adults
•Renal impairment
•Hepatic impairment
•Critical illness
|
|
|
Term
Special Population Use IN Childern |
|
Definition
Tetracyclines should not be used in children younger than 8 years of age because of their effectes on teeth and bones. |
|
|
Term
Special Population In Adults |
|
Definition
- A major concern with the use of tetracyclines and sulfonamides in older adults is renal impairment
- In younger adsults a fluid intake of 2 liters daily is needed to reduce formation of crystals & stones in the urinary tract.
- Severe skin reactions and bone marrow depression are most often reported w/ combination of trimethoprin-sulfamethoxazole
|
|
|
Term
Special Population With Renal Impairment |
|
Definition
- As discussed previously, most tetracyclines are contraindicated in patients w/ renal impairment. High concentrations of tetracyclines inhibit protein synthesis in human cells.
|
|
|
Term
Special Population With Renal Impairment |
|
Definition
Azotemia increased blood urea nitrogen, hyperphosphatemia, hyperkalemia, & acidosis.
Acute renal failure (ARF) has occurred when the drugs or their metabolites precipitated in renal tubules and caused obstruction. ARF is rarely associated with newer sulfonamides. |
|
|
Term
USE In Patients With Hepatic impairment |
|
Definition
Tetracyclines are generally contraindicated in pregnant women because they may cause fatal heptic necrosis in the mother as fetus. |
|
|
Term
|
Definition
Tetracyclines may be used to treat sepsis caused by rickettsial, chlamydial, or mycoplasma infection and pulmonary infection caused by M. pneumoniae or Legionella pneumophila |
|
|
Term
Doxycycline or Minocycline |
|
Definition
Given to renal patients and critical ill |
|
|